Raymond James & Associates Personalis, Inc. Transaction History

Raymond James & Associates

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$3.27 - $8.76 $38,563 - $103,306	-11,793 Closed	0 $0
Q1 2022 May 11, 2022	SELL	$7.56 - $14.3 $2,948 - $5,577	-390 Reduced 3.2%	11,793 $97,000
Q4 2021 Feb 08, 2022	SELL	$12.24 - $21.25 $378,277 - $656,731	-30,905 Reduced 71.73%	12,183 $174,000
Q3 2021 Nov 02, 2021	BUY	$16.69 - $26.05 $36,567 - $57,075	2,191 Added 5.36%	43,088 $829,000
Q2 2021 Aug 11, 2021	BUY	$18.15 - $27.75 $742,280 - $1.13 Million	40,897 New	40,897 $1.04 Million
Q1 2021 May 14, 2021	SELL	$20.71 - $51.02 $321,543 - $792,136	-15,526 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$21.84 - $44.0 $339,087 - $683,144	15,526 New	15,526 $568,000

30.1M

27.5K

85.4K

Ticker PSNL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 45,918,400
Market Cap $159M
Description
Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

Stay updated on Raymond James & Associates with notifications on news.